Other languages Xencor, Inc.

Equities

XNCR

US98401F1057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
18.26 ^USD	-4.00%		-5.63%	-13.99%

Jun. 14	Raymond James Adjusts Price Target on Xencor to $40 From $58, Maintains Strong Buy Rating	MT
Jun. 14	BMO Capital Adjusts Xencor's Price Target to $32 From $34, Keeps Outperform Rating	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xencor, Inc. Regains CD20 x CD3 Bispecific T-Cell Engager	Jun. 13
Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Xencor Names Bart Cornelissen as Chief Financial Officer	Apr. 09
Xencor Appoints Bart Cornelissen as Senior Vice President	Apr. 09
Xencor Insider Sold Shares Worth $293,519, According to a Recent SEC Filing	Mar. 07
Xencor, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27
Xencor Insider Sold Shares Worth $1,048,743, According to a Recent SEC Filing	Feb. 14
Xencor, Inc. Appoints Dane Leone as Senior Vice President, Corporate Strategy	Jan. 02
Xencor Insider Sold Shares Worth $941,670, According to a Recent SEC Filing	Dec. 29
Xencor, Inc. Enters into an Amended and Restated Collaboration and License Agreement with Genentech, Inc	Nov. 15
Xencor, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
Xencor, Inc. and OCM Life Sciences Portfolio LP, Entere into A Royalty Purchase Agreement	Nov. 07
Xencor Says Cancer Drug Candidates Showed Anti-Tumor Activity in Preclinical Trials	Nov. 03
Xencor Says CFO John Kuch to Retire in March	23-10-26
Xencor Announces Planned Retirement of Senior Vice President John Kuch	23-10-26
Xencor, Inc. Appoints Barbara J. Klencke to Board of Directors	23-09-19
Xencor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Insider Sell: Xencor	23-06-22
Xencor, Inc. Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress	23-05-30
Xencor Reports Q1 Loss, Lower Revenue	23-05-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Xencor, Inc.

Equities

XNCR

US98401F1057

Other languages

Filters